PRACTICE AREAS
- Home
- PRACTICE AREAS
C.R. Bard, a prominent medical device manufacturer, has faced numerous lawsuits related to its hernia mesh products. Plaintiffs have alleged that Bard's hernia mesh implants are defectively designed, leading to severe complications such as pain, infection, bowel obstruction, mesh migration, and organ perforation. These complications often necessitate additional surgeries, causing significant physical and emotional distress for patients.
The Bard hernia mesh products under scrutiny include the Bard Ventralex, Bard Perfix, Bard 3DMax, and Bard Composix. These products were intended to provide durable and effective treatment for hernias, but many recipients claim they have experienced adverse effects due to the mesh failing to perform as intended.
Lawsuits against C.R. Bard assert that the company failed to adequately warn patients and healthcare providers about the risks associated with their hernia mesh products. Additionally, it is alleged that Bard continued to market and sell the mesh despite being aware of its potential to cause harm. Plaintiffs seek compensation for medical expenses, lost wages, pain and suffering, and other related damages.
Find Out If You Qualify
The Paragard IUD, a popular non-hormonal contraceptive device, has been the subject of numerous lawsuits. Plaintiffs allege that the device can break upon removal, leading to severe injuries such as uterine perforation, organ damage, and the need for surgical intervention. These complications can result in significant pain, infertility, and long-term health issues.
The lawsuits claim that Teva Pharmaceuticals, the manufacturer of Paragard, failed to adequately warn users and healthcare providers about the risks of the device breaking during removal. Furthermore, it is alleged that Teva did not sufficiently test the device for safety before bringing it to market.
Victims of Paragard IUD complications are seeking compensation for their injuries, medical costs, lost income, and pain and suffering. These lawsuits highlight the need for comprehensive safety testing and transparent communication regarding potential risks associated with medical devices.
Find Out If You QualifyTepezza, a medication used to treat Thyroid Eye Disease (TED), has come under legal scrutiny due to allegations of causing hearing loss and tinnitus. Patients who were prescribed Tepezza have reported experiencing hearing-related issues, including permanent hearing damage and persistent ringing in the ears, which significantly impact their quality of life.
Lawsuits against Horizon Therapeutics, the maker of Tepezza, argue that the company failed to properly warn patients and doctors about the potential for hearing loss associated with the drug. It is also claimed that Horizon did not conduct adequate studies to fully understand the risk of these side effects before releasing the medication to the public.
Plaintiffs are seeking compensation for the medical expenses incurred due to hearing loss, loss of earning capacity, and the emotional toll of living with these side effects. The litigation aims to hold Horizon Therapeutics accountable for the alleged harm caused by Tepezza.
Find Out If You Qualify
The Bard PowerPort, a vascular access device used for administering medications and fluids, has been implicated in several lawsuits due to claims of device failure and resulting injuries. Plaintiffs allege that the PowerPort can fracture or migrate within the body, leading to severe complications such as infection, blood clots, and damage to veins and organs.
The lawsuits contend that Bard failed to provide adequate warnings about the risks of device failure and did not conduct sufficient testing to ensure the PowerPort's safety. Patients affected by these issues have had to undergo additional medical procedures to remove or replace the device, leading to further health risks and financial burdens.
Victims are pursuing legal action to obtain compensation for their medical expenses, pain and suffering, lost wages, and other damages. These cases underscore the importance of rigorous testing and transparent communication about the risks of medical devices.
Find Out If You QualifyOne Wheel, an electric self-balancing skateboard, has faced legal action due to allegations of safety defects leading to serious injuries. Plaintiffs claim that the device can suddenly stop or malfunction, causing riders to be thrown off balance and resulting in injuries such as fractures, concussions, and even death.
The lawsuits assert that Future Motion, the manufacturer of One Wheel, failed to adequately warn consumers about the potential dangers associated with the product. It is also alleged that the company did not take sufficient steps to improve the device's safety despite being aware of the risks.
Injured riders are seeking compensation for their medical bills, lost wages, pain and suffering, and other related damages. The litigation aims to hold Future Motion accountable for the safety issues and to prompt improvements in the design and warnings for the One Wheel.
Find Out If You Qualify
Suboxone, a medication used to treat opioid dependence, has been linked to tooth decay and other dental issues. Patients who have taken Suboxone report experiencing severe dental problems, including cavities, tooth loss, and gum disease. These complications have led to significant pain, extensive dental procedures, and financial burdens for affected individuals.
Lawsuits against Indivior, the manufacturer of Suboxone, allege that the company did not adequately warn users about the risk of dental problems associated with the medication. It is claimed that Indivior knew or should have known about these risks but failed to disclose them to patients and healthcare providers.
Plaintiffs are seeking compensation for their dental expenses, pain and suffering, and other related damages. These lawsuits highlight the need for comprehensive information about potential side effects of medications, allowing patients to make informed decisions about their treatment.
Find Out If You QualifyOzempic, a medication used to manage type 2 diabetes, has been linked to gallbladder issues, including gallstones and cholecystitis (inflammation of the gallbladder). Patients who have taken Ozempic and subsequently experienced gallbladder problems have filed lawsuits against Novo Nordisk, the drug's manufacturer.
The lawsuits claim that Novo Nordisk failed to adequately warn patients and healthcare providers about the risk of gallbladder issues associated with Ozempic. Plaintiffs allege that the company did not conduct sufficient studies to fully understand these risks before marketing the drug.
Affected individuals are seeking compensation for their medical expenses, pain and suffering, lost wages, and other damages. The litigation aims to hold Novo Nordisk accountable for the alleged harm caused by Ozempic and to ensure that potential side effects are clearly communicated to patients and doctors.
Find Out If You Qualify
Several baby food manufacturers have faced lawsuits over allegations that their products contain dangerous levels of heavy metals, including arsenic, lead, cadmium, and mercury. These heavy metals pose significant health risks to infants and young children, potentially leading to developmental delays, cognitive impairment, and other serious health issues.
The lawsuits claim that manufacturers failed to adequately test their products for heavy metal contamination and did not provide sufficient warnings to consumers. It is also alleged that the companies did not take necessary steps to mitigate the presence of these harmful substances in their baby foods.
Parents of affected children are seeking compensation for medical expenses, developmental therapies, and other related costs. The litigation aims to hold baby food manufacturers accountable for the safety of their products and to ensure stricter regulations and testing procedures are implemented.
Find Out If You QualifyAcetaminophen, commonly known by the brand name Tylenol, has been the subject of lawsuits alleging a link between prenatal exposure to the drug and the development of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in children. Plaintiffs claim that using Tylenol during pregnancy increased the risk of these neurodevelopmental disorders.
The lawsuits argue that Johnson & Johnson, the manufacturer of Tylenol, failed to provide adequate warnings about the potential risks associated with prenatal acetaminophen use. It is alleged that the company knew or should have known about these risks but did not disclose them to consumers and healthcare providers.
Parents of children diagnosed with ASD or ADHD are seeking compensation for medical expenses, special education costs, and other related damages. These lawsuits aim to raise awareness about the potential risks of acetaminophen use during pregnancy and to ensure that manufacturers provide clear and comprehensive safety information.
Find Out If You Qualify